摘要
脂质体作为药物载体能明显提高玻璃体内注射药物的安全性和有效性。现主要应用于治疗眼内感染、预防增生性玻璃体视网膜病变以及基因转染的载体。
出处
《眼科》
CAS
2003年第6期364-367,共4页
Ophthalmology in China
参考文献23
-
1[1]Metrikin DC,et al.Curr Opin Ophthalmol,1995,5(3):21-29.
-
2[2]Smolin G,et al.Am J Ophthalmol,1981,91(2):220-225.
-
3[3]Barza M,et al.Invest Ophthalmol Vis Sci,1987,28:893-900.
-
4[4]Stern WH,et al.Invest Ophthalmol Vis Sci,1987,28:907-911.
-
5[6]Fishman PH,et al.Invest Ophthalmol Vis Sci,1986,27(7):1103-1106.
-
6[7]Kim EK,et al.Yonsei Med J,1990,31(4):308-314.
-
7[8]Fiscella R,et al.Can J Ophthalmol,1987,22(6):307-309.
-
8[9]Zeng S,et al.Ophthalmology,1993,100(11):1640-1644.
-
9[10]Wiechens B,et al.Int Ophthalmol,1998-99,22(3):133-143.
-
10[11]Wiechens B,et al.Ophthalmologica,1999,213(2):120-128.
同被引文献23
-
1毕宏生,崔彦,张建华,王兴荣,解孝锋.5-氟尿嘧啶聚乳酸微球防治实验性增生性玻璃体视网膜病变的效果观察[J].中华眼科杂志,2006,42(1):37-41. 被引量：10
-
2MARTINEZ-SANCHO C,HERRERO-VANRELL R,NEGRO S.Vitamin A palmitate and acyclovir biodegradable microspheres for intraocular sustained release[J].Int J Pharm,2006,326(1-2):100-106.
-
3HU T,LE Q,WU Z,et al.Determination of doxorubicin in rabbbit ocular tissues and pharmacokinetics after intravitreal injection of a single dose of doxorubicin-loaded poly-β-hydroxybutyrate microspheres[J].J Pharm Biomed Anal,2007,43(1):263-269.
-
4KIM H,CSAKY KG.Nanoparticle-integrin antagonist C16Y peptide treatment of neovascularization in rats[J].J Control Release,2009,142(2):286-293.
-
5BARCIA E,HERRERO-VANRELL R,DIEZ A,et al.Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone[J].Exp Eye Res,2009,89(2):238-245.
-
6KAWAKAMI S,HARADA A,SAKANAKA K,et al.In vivo gene transfection via intravitreal injection of cationic liposome/plasmid DNA complexes in rabbits[J].Int J Pharm,2004,278(2):255-262.
-
7CARMEN C,RUIZ R,CORDERO E,et al.Determination and pharmacokinetic profile of liposomal foscrnet in rabbit ocular tissues after intravitreal administration[J].Exp Eye Res,2009,88(3):528-534.
-
8CAMELO S,LAJAVARDI L,BOCHOT A,et al.Protective effect of intravitreal injection of vasoactive intestinal peptide(VIP)-loaded liposomes on experimental autoimmune uveoretinitis[J].J Ocul Pharmacol Ther,2009,25(1):9-21.
-
9LAJAVARDI L,CAMELO S,AGNELY F,et al.New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis[J].J Control Release,2009,139(1):22-30.
-
10Hui YN,Liang HC,Cai YS,et al.Corticosteroid and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages[J].Graefe's Arch Clin Ophthalmol,1993,231 (2):109-114.
-
1陈红.头孢唑啉治疗眼内感染1例[J].安徽医科大学学报,1997,32(4):499-500.
-
2严良.抗菌眼药的使用原则[J].家庭用药,2010(6):35-35.
-
3Hariprasad S.M.,Blinder K.J.,Shah G.K.,韩静.0.5%莫西沙星眼液局部给药后在人房水和玻璃体中的渗透性药代动力学研究[J].世界核心医学期刊文摘（眼科学分册）,2005,0(6):19-19. 被引量：1
-
4张玲,李春霞,等.氧氟沙星滴眼液在白内障术前的应用效果[J].中华临床医药杂志（北京）,2002,3(2):64-64.
-
5田景振,邱海霞,刘瑾,梅兴国.氟尿嘧啶聚乳酸微球在PVR家兔体内的研究[J].中国医药工业杂志,2006,37(2):106-109. 被引量：2
-
6潘细贵,罗顺德,蔡鸿生,雷嘉川,张先洲.乳酸左氧氟沙星滴眼液在兔眼房水中的药代动力学[J].中国药房,2001,12(8):456-457. 被引量：1
-
7索南措,王玉瑾,张燕.高原地区老年性白内障围术期用药与术后感染的相关性研究[J].中华医院感染学杂志,2015,25(9):2007-2009. 被引量：5
-
8高媛,张明昌.环氧化酶-2与眼部疾病的关系[J].国外医学（眼科学分册）,2005,29(4):245-248. 被引量：3
-
9傅海涛,周艳,周兴德,蒋秀芹,张迎秋,高云霞,崔连华,朱德全.盐酸左氧氟沙星滴眼液对白内障术前结膜囊的清洁作用[J].山东大学基础医学院学报,2003,17(5):302-303. 被引量：4
-
10蔡鸿生,罗顺德,刘强,雷嘉川,李荣凌,张先洲.乳酸左氧氟沙星滴眼液在兔眼中的药动学[J].中国医院药学杂志,2001,21(7):391-393. 被引量：22
